189 related articles for article (PubMed ID: 34971615)
21. Postpartum long-acting reversible contraception among privately insured: U.S. National analysis 2007-2016, by term and preterm birth.
Shaw JG; Goldthwaite LM; Marić I; Shaw KA; Stevenson DK; Shaw GM
Contraception; 2023 Sep; 125():110065. PubMed ID: 37210023
[TBL] [Abstract][Full Text] [Related]
22. An initiative to implement immediate postpartum long-acting reversible contraception in rural New Mexico.
Palm HC; Degnan JH; Biefeld SD; Reese AL; Espey E; Hofler LG
Am J Obstet Gynecol; 2020 Apr; 222(4S):S911.e1-S911.e7. PubMed ID: 31978431
[TBL] [Abstract][Full Text] [Related]
23. Postpartum contraception in publicly-funded programs and interpregnancy intervals.
Thiel de Bocanegra H; Chang R; Menz M; Howell M; Darney P
Obstet Gynecol; 2013 Aug; 122(2 Pt 1):296-303. PubMed ID: 23969798
[TBL] [Abstract][Full Text] [Related]
24. Contraceptive Receipt Among First-Trimester Abortion Clients and Postpartum Women in Urban Mexico.
Darney BG; Fuentes-Rivera E; Saavedra-Avendaño B; Sanhueza-Smith P; Schiavon R
Int Perspect Sex Reprod Health; 2020 Dec; 46(Suppl 1):35-43. PubMed ID: 33326398
[TBL] [Abstract][Full Text] [Related]
25. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
[TBL] [Abstract][Full Text] [Related]
26. Contraception after delivery and short interpregnancy intervals among women in the United States.
White K; Teal SB; Potter JE
Obstet Gynecol; 2015 Jun; 125(6):1471-1477. PubMed ID: 26000519
[TBL] [Abstract][Full Text] [Related]
27. Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States.
Fang NZ; Westhoff CL
Am J Obstet Gynecol; 2022 Sep; 227(3):477.e1-477.e7. PubMed ID: 35569515
[TBL] [Abstract][Full Text] [Related]
28. Medicaid reimbursement program for immediate postpartum long-acting reversible contraception improves uptake regardless of insurance status.
Koch SK; Paul R; Addante AN; Brubaker A; Kelly JC; Raghuraman N; Madden T; Tepe M; Carter EB
Contraception; 2022 Sep; 113():57-61. PubMed ID: 35588793
[TBL] [Abstract][Full Text] [Related]
29. Postpartum Contraceptive Use Among Denver-Based Adolescents and Young Adults: Association with Subsequent Repeat Delivery.
Harrison MS; Zucker R; Scarbro S; Sevick C; Sheeder J; Davidson AJ
J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):393-397.e1. PubMed ID: 32251837
[TBL] [Abstract][Full Text] [Related]
30. Policy change is not enough: engaging provider champions on immediate postpartum contraception.
Okoroh EM; Kane DJ; Gee RE; Kieltyka L; Frederiksen BN; Baca KM; Rankin KM; Goodman DA; Kroelinger CD; Barfield WD
Am J Obstet Gynecol; 2018 Jun; 218(6):590.e1-590.e7. PubMed ID: 29530670
[TBL] [Abstract][Full Text] [Related]
31. Immediate Postpartum Long-Acting Reversible Contraceptive Use Following State-Specific Changes in Hospital Medicaid Reimbursement.
Steenland MW; Vatsa R; Pace LE; Cohen JL
JAMA Netw Open; 2022 Oct; 5(10):e2237918. PubMed ID: 36269353
[TBL] [Abstract][Full Text] [Related]
32. Feasibility and acceptability of a toolkit-based process to implement patient-centered, immediate postpartum long-acting reversible contraception services.
Moniz MH; Dalton VK; Smith RD; Owens LE; Landis-Lewis Z; Peahl AF; Van Kainen B; Punch MR; Wetmore MK; Bonawitz K; Kolenic GE; Dehlendorf C; Heisler M
Am J Obstet Gynecol; 2022 Mar; 226(3):394.e1-394.e16. PubMed ID: 34655551
[TBL] [Abstract][Full Text] [Related]
33. Influence of Medicaid expansion on short interpregnancy interval rates in the United States.
Patel KS; Bakk J; Pensak M; DeFranco E
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100484. PubMed ID: 34517145
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Group Prenatal Care on Interpregnancy Interval.
Keller JM; Norton JA; Zhang F; Paul R; Madden T; Raghuraman N; Stout MJ; Carter EB
Am J Perinatol; 2023 Nov; 40(15):1659-1664. PubMed ID: 34891199
[TBL] [Abstract][Full Text] [Related]
35. Immediate postpartum provision of long-acting reversible contraception.
Goldthwaite LM; Shaw KA
Curr Opin Obstet Gynecol; 2015 Dec; 27(6):460-4. PubMed ID: 26536209
[TBL] [Abstract][Full Text] [Related]
36. Disparities in postpartum contraceptive use among immigrant women with restricted Medicaid benefits.
Rodriguez MI; McConnell KJ; Skye M; Kaufman M; Caughey AB; Lopez-Defede A; Darney BG
AJOG Glob Rep; 2022 Feb; 2(1):100030. PubMed ID: 36274968
[TBL] [Abstract][Full Text] [Related]
37. Medicaid and receipt of interval postpartum long-acting reversible contraception.
Wilkinson B; Ascha M; Verbus E; Montague M; Morris J; Mercer B; Arora KS
Contraception; 2019 Jan; 99(1):32-35. PubMed ID: 30194927
[TBL] [Abstract][Full Text] [Related]
38. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
39. Does co-location of medication assisted treatment and prenatal care for women with opioid use disorder increase pregnancy planning, length of interpregnancy interval, and postpartum contraceptive uptake?
Collier KW; MacAfee LK; Kenny BM; Meyer MC
J Subst Abuse Treat; 2019 Mar; 98():73-77. PubMed ID: 30665607
[TBL] [Abstract][Full Text] [Related]
40. Patients' Experiences with an Immediate Postpartum Long-Acting Reversible Contraception Program.
Wallace Huff C; Potter JE; Hopkins K
Womens Health Issues; 2021; 31(2):164-170. PubMed ID: 33323329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
